Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A **lectin-binding carbohydrate moiety** refers to any carbohydrate structure (glycan or oligosaccharide motif) on the surface of cells or glycoproteins that is recognized and reversibly bound by a lectin via its carbohydrate recognition domain (CRD)[1][4]. These carbohydrate motifs usually consist of 1–4 monosaccharide units and present specific structures, such as high-mannose, complex N-glycans, sialylated, galactosylated, or GlcNAc-containing motifs, that determine lectin-binding specificity[1][2][3]. Lectin-glycan interactions are critical in a variety of biological processes, including cell–cell recognition, signaling, immune responses, host–pathogen interactions, and plant–microbe symbiosis[1][3][4]. The carbohydrate portion is not a standalone protein, gene, or canonical receptor but refers to the molecular structure or epitope recognized by lectins[1][4]. **Key context:** - The phrase is **not** the name of a protein, receptor, or traditional drug target. - There are no abbreviations or drug-targeting mechanisms associated with this generic glycan term. - Specific examples of lectin-binding carbohydrate motifs include high-mannose glycans, GlcNAc-containing trimers (recognized by Nictaba lectin), galactosyl or sialyl motifs, etc.[1][2][3] - Lectins themselves may be therapeutic targets or tools, but the glycan motifs they bind are not commonly targeted by drugs directly—they can be targets for glycosylation pathway inhibitors or for diagnostic purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lectin-binding carbohydrate moiety.